New product licenses total 19
The Korea Food and Drug Administration announced that licenses for new products totaled 19 as of the end of last April. Details:
Status of new products
|
Product Remarks |
Company |
Indications |
Remarks |
|
Cresto tab. |
AstraZeneca Korea |
Hyperlipemia |
Clinical use |
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
